Reduced serum free carnitine as well as reduced levels of 3-keto-VPA, the main metabolite of -oxidation of VPA, was first reported in 1982 by Bohles and coworkers [53] in a 3-year-old girl who developed acute liver disease with typical features of Reye's syndrome after treatment with VPA for 6 months
Maximum daily dose should not exceed 3,000 mg, with caution in patients with liver disease or alcohol use
There is no official contraindication to taking gabapentin and Wegovy together
It may also influence hormones involved in weight regulation
Dual GLP-1/glucagon receptor agonists, including mazdutide, integrate appetite suppression with increased energy expenditure and fat oxidation, while triple GLP-1/GIP/glucagon agonists, such as retatrutide, further augment these mechanisms through multi-pathway receptor engagement
Are You a Good Candidate for Semaglutide